Autologous bone marrow stem cells transplantation for diabetes mellitus

Status

Recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-12001883

Enrollment

Unknown

Registered

2012-01-05

Start date

2010-12-17

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

1:routine treatment

2:stem cells+routine treatment

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed type 2 diabetes; 2. Sex is not limited; 3. Aged 18-60 years old; 4. BMI 19 to 24kg/m^2; 5. HbA1C>=7.0%; 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined serious cardio-cerebrovascular; 2. Liver and kidney function deficiency; 3. Infectious disease; 4. Hematological Diseases; 5. Autoimmune disease; 6. Malignant tumor; 7. Psychotic patients; 8. Allergy to the contrast media.

Design outcomes

Primary

Measure	Time frame
HbA1C;C-peptide;Tumor marker;	—

Secondary

Measure	Time frame
BMI;Urine albumin/urine creatinin;	—

Countries

China

Contacts

Public ContactDaijin Ji

jidaijin@163.com+86 13032896171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026